Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00956800 · ClinicalTrials.gov registry record · NA

Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software

A NA study of Diabetes, sponsored by Columbus Research Foundation.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT00956800 is a NA study of Diabetes that has completed, run by Columbus Research Foundation. The registered enrollment target is 100 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00956800, a NA study of Diabetes, has completed, sponsored by Columbus Research Foundation.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if providing some care to diabetic patients remotely, using Accuchek 360 yields at least the same clinical results for their diabetes care, according to existing guidelines, as providing all care to patients in person.

Conditions Studied

Interventions

  • OTHER Accu-Chek 360 software
  • OTHER Normal care

Study Locations (1)

Georgia

  • Columbus Research Foundation - Columbus

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2009-09
Est. Completion 2011-06
Phase NA

Sponsor

Columbus Research Foundation

1 total trials

What the Registry Record Tells You About NCT00956800

The ClinicalTrials.gov registry entry for NCT00956800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Columbus Research Foundation, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Accu-Chek 360 software is the first listed.

NCT00956800 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00956800 about?

NCT00956800 is a clinical study titled "Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software". The purpose of this study is to determine if providing some care to diabetic patients remotely, using Accuchek 360 yields at least the same clinical results for their diabetes care, according to existing guidelines, as providing all care to patients in person.

What is the current status of trial NCT00956800?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2009-09. Estimated completion is 2011-06.

What conditions does trial NCT00956800 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT00956800?

The interventions under investigation include: Accu-Chek 360 software (OTHER), Normal care (OTHER).

Who is sponsoring clinical trial NCT00956800?

This trial is sponsored by Columbus Research Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00956800 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.